Dr. Roy Handelsman of HRC Fertility Encino was recently featured in a HuffPost article discussing the significant renaming of Polycystic Ovary Syndrome (PCOS) to Polyendocrine Metabolic Ovarian Syndrome (PMOS), a change that better reflects the complexity of the condition and its impact beyond ovarian health. In the article, Dr. Handelsman explains why the term “PCOS” has long been considered misleading, as it incorrectly suggests that patients develop ovarian cysts when the condition actually involves disrupted follicle development, hormonal imbalance, and significant metabolic effects. She highlights how the new name more accurately represents the endocrine, metabolic, and reproductive components of the condition, including its links to insulin resistance, diabetes, high blood pressure, infertility, and other long-term health concerns.

Dr. Handelsman also discusses how this updated terminology may help improve awareness, reduce delays in diagnosis, and encourage more comprehensive treatment approaches for the millions of women affected by this condition worldwide.

Read Dr. Handelsman’s full commentary in HuffPost and learn more about what this name change means for patients and providers alike.